EcoDrugPlus

Glutathione S-Transferase Pi 1

Ensembl ID : ENSCHAG00000003083
Gene Symbol: GSTP1
1 Cross references
161 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSCHAG00000012443
Gene Symbol: GSK3AB
1 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSCHAG00000024359
Gene Symbol: GSK3BA
1 Cross references
209 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSCHAG00000023643
Gene Symbol: LOC105911913
3 Cross references
164 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSCHAG00000026206
Gene Symbol: LOC105892068
3 Cross references
181 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSCHAG00000012108
Gene Symbol: LOC105892009
3 Cross references
174 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSCHAG00000023319
Gene Symbol: GHSR
3 Cross references
200 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1-Like

Ensembl ID : ENSCHAG00000009926
Gene Symbol: LOC105908527
3 Cross references
196 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCHAG00000019638
Gene Symbol: GUCY1A1
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCHAG00000019404
Gene Symbol: GUCY1A2
1 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCHAG00000019652
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSCHAG00000012140
Gene Symbol: HSP90AB1
1 Cross references
357 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).